fbpx Skip to main content


Congyang (Tom) Wu



As Asia Pacific Head, World Without Disease Accelerator (WWDA), Tom is responsible for the overall strategic and executional efforts of the WWDA in Asia Pacific, with an initial focus in China, Taiwan, Japan and Singapore. He also supports the existing WWDA Ventures: Type 1 Diabetes, Colorectal Cancer and the Healthy Baby Initiative. In addition, Tom contributes to the strategic planning for potential future venture opportunities and plays an important role supporting the Lung Cancer Initiative (LCI) at Johnson & Johnson.

In his previous role with Johnson & Johnson, Tom was responsible for the Consumer Health Self-Care R&D team in Asia Pacific and Janssen OTC R&D for China, as well as leading the Consumer Health efforts for the LCI.

Prior to joining Johnson & Johnson in 2016, Tom served as Head for the Greater China Project Management Office at Abbott. Prior to Abbott, he held positions with Novartis as a Strategy & Business Development Manager and also served in a variety of roles in R&D, Regulatory Affairs and Supply Chain across China, Belgium, Italy and the United Kingdom. Before Novartis, Tom was with Schlumberger in the US and Latin America for two years, and also worked for Bioduro, a subsidiary of the global contract research organization PPD, in Beijing, China. Tom graduated with a master’s degree in biology from Tsinghua University.